At an investor update at the end of last week, Lonza has announced its "One Lonza" restructuring strategy, which aims to reorganize its CDMO business, simplify its...

Clariant is expanding its Cangzhou production site to manufacture the multifunctional additive Nylostab S-EED.

Danish drugmaker Novo Nordisk plans to invest 8.5 billion Danish kroner (about €1.14 billion) to establish a new production facility in Odense, Denmark.

Italian drugmaker Newron Pharmaceuticals and EA Pharma, a subsidiary of Japan’s Eisai, today have entered into a license agreement to develop, manufacture and...

OQ Chemicals has sold its ester plant in Amsterdam, The Netherlands, to Swedish specialty chemicals group Perstorp.

An Attractive and Highly Sought-after Business Location
The life sciences sector, encompassing biotechnology, pharmaceuticals and medical technology, is developing...

The Italian Olon Group, a leading international supplier of active pharmaceutical ingredients (APIs), presents the 2023 Corporate Sustainability Report and confirms the...

Ineos and its partners Harbour Energy and Nordsøfonden have taken the final investment decision (FID) into the first commercial phase ‘Greensand Future’ with storage...